Adult Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Recent evidence has indicated that heterogeneous nuclear ribonucleoprotein A2B1 (hnRNP A2B1) is overexpressed in human glioblastoma tissue and enhances glioblastoma invasion in vitro.
|
31283707 |
2019 |
Adult Liver Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We show that the splicing factors hnRNP A1 and hnRNP A2 are up-regulated in HCC tumors derived from inflammation-induced liver cancer mouse model.
|
24572810 |
2014 |
Adult Meningioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In addition, we have for the first time identified significantly higher hnRNP family expression in meningioma and pituitary adenoma compared to normal brain tissue.
|
31698554 |
2019 |
Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Based on data showing that the two RNA binding proteins (RBPs), Fragile-X Mental Retardation Protein (FMRP) and heteronuclear Ribonucleoprotein C (hnRNP C), exert an opposite control on APP translation, we have analyzed whether expression and translation of these two RBPs vary in relation to changes in APP protein and mRNA levels in the AD brain at 1, 3, and 6 months of age.
|
26048669 |
2016 |
Amyotrophic Lateral Sclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
Another hnRNP protein, hnRNPA3, has been found to be associated with the ALS/frontotemporal dementia protein C9orf72.
|
29131108 |
2017 |
Amyotrophic Lateral Sclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
Linking hnRNP Function to ALS and FTD Pathology.
|
29867335 |
2018 |
Amyotrophic Lateral Sclerosis
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
The interacting region in each of these proteins was their glycine-rich domain, the domain most frequently mutated in hnRNP-related proteins that cause ALS.
|
25616961 |
2015 |
Astler-Coller B1 Rectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
To test the effect of hnRNP B1 on DNA repair, we performed comet assay after irradiation, using normal human bronchial epithelial (HBE) cells treated with siRNA for hnRNP A2/B1: reduction of hnRNP B1 treated with siRNA for hnRNP A2/B1 induced faster DNA repair in normal HBE cells.
|
15964549 |
2005 |
Bladder Neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We further show that the reduction of miR-141-3p expression by p63α directly releases its inhibition of 3' untranslated region (UTR) activity of AU-rich element RNA-binding factor 1 (AUF1) mRNA, thereby increasing AUF1 protein translation and further resulting in degradation of c-Myc mRNA, which, in turn, reduces cyclin D1 gene transcription and BC cell anchorage-independent growth.
|
30104251 |
2018 |
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
|
26367347 |
2015 |
Breast Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Most importantly, down regulation of hnRNP A18 decreases proliferation, invasion and migration in addition to significantly reducing tumor growth in two mouse xenograft models, melanoma and breast cancer.
|
26824423 |
2016 |
Carcinogenesis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Taken together, our data indicate that hnRNP Q1 is a novel trans-acting factor that binds to Aurora-A mRNA 5'-UTRs and regulates its translation, which increases cell proliferation and contributes to tumorigenesis in colorectal cancer.
|
28079881 |
2017 |
Carcinogenesis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Considering these results, we assume that overexpression of hnRNP B1 occurring in the early stage of carcinogenesis inhibits DNA-PK activity, resulting in subsequent accumulation of erroneous rejoining of DNA double-strand breaks, causing tumor progression.
|
15964549 |
2005 |
Carcinoma of bladder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We further show that the reduction of miR-141-3p expression by p63α directly releases its inhibition of 3' untranslated region (UTR) activity of AU-rich element RNA-binding factor 1 (AUF1) mRNA, thereby increasing AUF1 protein translation and further resulting in degradation of c-Myc mRNA, which, in turn, reduces cyclin D1 gene transcription and BC cell anchorage-independent growth.
|
30104251 |
2018 |
Carcinoma of lung
|
0.060 |
Biomarker
|
disease |
BEFREE |
Considering the problems involved in prevention of human lung cancer, growth inhibition of human lung cancer cell line A549 was studied with emphasis on two parameters: green tea polyphenols, such as (-)-epigallocatechin gallate (EGCG) and (-)-epicatechin gallate (ECG); and heterogeneous nuclear ribonucleoprotein B1 (hnRNP B1), a new biomarker of human lung cancer which is highly expressed in the very early stages of human lung cancer.
|
12012004 |
2002 |
Carcinoma of lung
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
The protein alpha CP-4 (also known as hnRNP E4) is an RNA binding protein encoded by a gene at 3p21, one of the most common altered regions in lung cancer.
|
17973258 |
2008 |
Carcinoma of lung
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Our results also suggest that the expression and processing of each hnRNP protein in lung cancer is independently regulated and is not exclusively related to proliferation status.
|
12871776 |
2003 |
Carcinoma of lung
|
0.060 |
Biomarker
|
disease |
BEFREE |
This detection method was used to detect mRNA heterogeneous nuclear ribonucleoproteins (hnRNP B1) in two cancer cell lines, CL1-0 and CL1-5. hnRNP B1 is an mRNA biomarker that is overexpressed in lung cancer tissue in the early stage of cancer and can be found in the serum and plasma of lung cancer patients.
|
23511627 |
2013 |
Carcinoma of lung
|
0.060 |
Biomarker
|
disease |
BEFREE |
This paper briefly reviews four topics related to mechanisms of action of tea polyphenols: (I) identification of the genes commonly affected by EGCG, as demonstrated by Clontech's Atlas cDNA Expression Array; (II) the significance of heterogeneous nuclear ribonucleoprotein B1 (hnRNP B1) as a new biomarker for early detection of lung cancer, and inhibition of its expression by EGCG; (III) the synergistic or additive effects of EGCG with the cancer preventive agents, sulindac and tamoxifen, on induction of apoptosis in PC-9 cells and on inhibition of intestinal tumor development in multiple intestinal neoplasia (Min) mice; (IV) the results of a 10 year prospective cohort study demonstrating the effectiveness of daily consumption of green tea in preventing cancer, and a prototype study for developing green tea beverage as cancer preventive.
|
11506822 |
2001 |
Carcinoma of lung
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Using total RNA extracted from 600 mul of plasma, we detected hnRNP B1 mRNA in 39.1% (9/23) of lung cancer patients, with levels ranging from 1.9 to 19,045.5 copies/100 ng RNA, and in 5.2% (5/97) of healthy volunteers.
|
18461365 |
2008 |
Cataract
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Central neuroblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, we investigated whether overexpression of the hnRNP C variants hnRNP C1 and C2 changed the expression of myelination-related genes in the human neuroblastoma cell line SK-N-SH.
|
21684615 |
2011 |
Childhood Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Recent evidence has indicated that heterogeneous nuclear ribonucleoprotein A2B1 (hnRNP A2B1) is overexpressed in human glioblastoma tissue and enhances glioblastoma invasion in vitro.
|
31283707 |
2019 |
Childhood Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Conversely, HNRPDL silencing inhibited colony-forming cell (CFC) production of CML CD34<sup>+</sup> cells and attenuated BCR-ABL induced leukemia.
|
31488872 |
2020 |
Childhood Neuroblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, we investigated whether overexpression of the hnRNP C variants hnRNP C1 and C2 changed the expression of myelination-related genes in the human neuroblastoma cell line SK-N-SH.
|
21684615 |
2011 |